Literature DB >> 28449354

Prevalence of, and work-related risk factors for, hand eczema in a Norwegian general population (The HUNT Study).

Hilde K Vindenes1,2, Cecilie Svanes1,3, Stein H L Lygre1, Bjørg-Eli Hollund1,4, Arnulf Langhammer5, Randi J Bertelsen1,4.   

Abstract

BACKGROUND: Chemical exposures at work and at home may cause hand eczema. However, this has been scarcely described for Norway.
OBJECTIVES: To investigate the prevalence of, and occupational risk factors for, hand eczema in Norway.
METHODS: Among 50 805 respondents (aged ≥20 years) to the third Nord-Trøndelag Health Study (HUNT3), 5757 persons reported ever having hand eczema, and 4206 answered a hand eczema questionnaire.
RESULTS: The lifetime prevalences of hand eczema were 8.4% in men and 13.8% in women (p < 0.001), with onset at age ≤10 years in 24% (men) and 20% (women), and onset at age ≥30 years in 37% (men) and 25% (women) (p < 0.001). Work-related hand eczema affected 4.8% of the population, and was most frequently associated with health/social work (29%) and occupational cleaning (20%) in women, and with farming (26%) and industrial occupations (27%) in men. Cleaning detergents (75%) and other chemicals (36%) were the most common exacerbating factors.
CONCLUSIONS: The prevalence of hand eczema was 11.3%, and that of work-related hand eczema was 4.8%. Hand eczema was more common in women than in men, but with a later onset in men. Cleaning detergents were the most common aggravating factors. A large proportion of the Nord-Trøndelag population is employed in farming, providing the possibility to identify farming as an important risk factor for hand eczema.
© 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  HUNT; atopic dermatitis; epidemiology; hand eczema; occupational

Mesh:

Year:  2017        PMID: 28449354     DOI: 10.1111/cod.12800

Source DB:  PubMed          Journal:  Contact Dermatitis        ISSN: 0105-1873            Impact factor:   6.600


  7 in total

1.  A job-exposure matrix addressing hand exposure to wet work.

Authors:  Tamara Lund; Esben Meulengrath Flachs; Jennifer Astrup Sørensen; Niels Erik Ebbehøj; Jens Peter Bonde; Tove Agner
Journal:  Int Arch Occup Environ Health       Date:  2019-04-16       Impact factor: 3.015

2.  Hand eczema among healthcare workers in Guangzhou City: a cross-sectional study.

Authors:  Danqi Huang; Zengqi Tang; Xiaonan Qiu; Xiuting Liu; Zhixuan Guo; Bin Yang; Qing Guo; Hui Xiong
Journal:  Ann Transl Med       Date:  2020-12

3.  Topical 0.05% clobetasol cream in the treatment of chronic hand eczema: A protocol for systematic review and meta-analysis.

Authors:  Mingyi Jing; Qianying Yu; Baohua Zhu; Fan Yuan; Jie Zhang; Li Peng; Wenxia Lin; Mingling Chen
Journal:  Medicine (Baltimore)       Date:  2021-03-12       Impact factor: 1.817

4.  Chronic Hand Eczema Guidelines From an Expert Panel of the International Eczema Council.

Authors:  Jonathan I Silverberg; Emma Guttman-Yassky; Tove Agner; Robert Bissonnette; David E Cohen; Eric Simpson; Andreas Wollenberg; Jacob P Thyssen
Journal:  Dermatitis       Date:  2021 Sep-Oct 01       Impact factor: 4.845

5.  Exposure and work-related factors in subjects with hand eczema: Data from a cross-sectional questionnaire within the Lifelines Cohort Study.

Authors:  Marjolein J Brands; Laura Loman; Marie L A Schuttelaar
Journal:  Contact Dermatitis       Date:  2022-03-15       Impact factor: 6.419

6.  Hand eczema-A growing dermatological concern during the COVID-19 pandemic and possible treatments.

Authors:  Leszek Blicharz; Joanna Czuwara; Zbigniew Samochocki; Mohamad Goldust; Sylwia Chrostowska; Małgorzata Olszewska; Lidia Rudnicka
Journal:  Dermatol Ther       Date:  2020-06-18       Impact factor: 3.858

Review 7.  Lifestyle factors and hand eczema: A systematic review and meta-analysis of observational studies.

Authors:  Laura Loman; Marjolein J Brands; Anna A L Massella Patsea; Klaziena Politiek; Bernd W M Arents; Marie L A Schuttelaar
Journal:  Contact Dermatitis       Date:  2022-04-02       Impact factor: 6.419

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.